Related Experiment Video
Updated: Aug 16, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
Rational pharmacotherapy in early psychosis
1Medical Assessment Program for Schizophrenia, Centre for Addiction and Mental Health, 250 College Street, Totonto, Ontario M5T 1R8, Canada. gary_remington@camh.net
Background:
An increased focus in research specific to first-episode schizophrenia has provided a rapidly growing body of evidence that can be directly translated to clinical practice.
Aims:
To provide clinical recommendations specific to effective pharmacotherapy of first-episode schizophrenia.
Method:
Evidence from clinical trials focused on the first-episode population is combined with data from other areas of investigation.
Results:
In first-episode psychosis, when to initiate treatment is not always clear, being intimately linked to challenges regarding early detection and diagnosis. There may be differences in antipsychotic dosing, patterns of response and sensitivity to side-effects. Adherence appears to be even more problematic at this stage.
Conclusions:
Clinicians currently treating early psychosis have considerably more information to guide their decision-making. However, the speed at which the field is growing is a reminder to treat this knowledge as a work in progress.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Psychosis and Antipsychotic Drugs: Overview
Drug Therapy
Antianxiety Medications
Antipsychotic Drugs: Typical and Atypical Agents
Rational Emotive Behavior Therapy
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...